The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Schwarz, M. J.
* Articles by Müller, N.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Schwarz, M. J.
* Articles by Müller, N.
Related Collections
* Neurophysiology
* Schizophrenia Spectrum Disorders
* Molecular Biology
Am J Psychiatry 156:1103-1104, July 1999
© 1999 American Psychiatric Association


Brief Report

Antibodies to Heat Shock Proteins in Schizophrenic Patients: Implications for the Mechanism of the Disease

Markus J. Schwarz, M.D., Michael Riedel, M.D., Rudolf Gruber, M.D., Manfred Ackenheil, M.D., and Norbert Müller, M.D.

OBJECTIVE: The involvement of heat shock proteins has been determined in the pathophysiology of several disorders of the central nervous system, including multiple sclerosis. To elucidate their role in schizophrenia, the authors investigated antibody titers to heat shock proteins in unmedicated and medicated patients with schizophrenia. METHOD: Using the enzyme-linked immunosorbent assay technique, the authors measured titers of antibodies to 60 kilodaltons (kD) heat shock proteins (HSP60) and 70 kD heat shock proteins (HSP70) in 30 patients with schizophrenia before and during neuroleptic treatment and compared the titers with those of 31 healthy individuals. RESULTS: Ten (33%) of 30 patients with schizophrenia but only one (3%) of 31 healthy individuals showed immunoreactivity to HSP60 or HSP70. The authors found especially high anti-HSP70 titers in never-medicated patients. High anti-HSP60 titers were mainly found in patients who were being treated with neuroleptics. CONCLUSIONS: Since heat shock proteins are involved in diverse neuroprotective mechanisms, antibodies against heat shock proteins may inhibit neuroprotection. The authors discuss the implications of these findings for schizophrenia.




This article has been cited by other articles:


Home page
PsychosomaticsHome page
A. A. Canuso, R. N. Mclay, J. H. Bennett, J. M. Pyne, K. B. Munoz, and K. A. Stenback
Schizophreniform Disorder After Heat Injury in a Military Recruit
Psychosomatics, July 1, 2008; 49(4): 345 - 346.
[Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. Clarimon, J. Bertranpetit, M. Boada, L. Tarraga, and D. Comas
HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease
J Geriatr Psychiatry Neurol, September 1, 2003; 16(3): 146 - 150.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org